| Year |
Citation |
Score |
| 2017 |
Roche DJ, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology. PMID 28357460 DOI: 10.1007/S00213-017-4607-8 |
0.467 |
|
| 2017 |
Ray LA, Bujarski S, Shoptaw S, Roche DJ, Heinzerling K, Miotto K. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28091532 DOI: 10.1038/Npp.2017.10 |
0.583 |
|
| 2016 |
Green R, Bujarski S, Roche DJ, Ray LA. Relationship between negative affect and smoking topography in heavy drinking smokers. Addictive Behaviors. 61: 53-57. PMID 27240211 DOI: 10.1016/J.Addbeh.2016.05.016 |
0.54 |
|
| 2016 |
Roche DJ, Ray LA, Yardley MM, King AC. Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers. Current Addiction Reports. 3: 125-137. PMID 27162709 DOI: 10.1007/S40429-016-0081-3 |
0.626 |
|
| 2016 |
Roche DJ, Yardley MM, Lunny KF, Louie SG, Davies DL, Miotto K, Ray LA. A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder. Alcoholism, Clinical and Experimental Research. PMID 27087145 DOI: 10.1111/Acer.13064 |
0.554 |
|
| 2016 |
Ray LA, Bujarski S, Roche DJ. Subjective Response to Alcohol as a Research Domain Criterion. Alcoholism, Clinical and Experimental Research. 40: 6-17. PMID 26727518 DOI: 10.1111/Acer.12927 |
0.578 |
|
| 2015 |
Courtney KE, Schacht JP, Hutchison K, Roche DJ, Ray LA. Neural substrates of cue reactivity: association with treatment outcomes and relapse. Addiction Biology. PMID 26435524 DOI: 10.1111/Adb.12314 |
0.483 |
|
| 2015 |
Bujarski S, Hutchison KE, Roche DJ, Ray LA. Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers. Alcoholism, Clinical and Experimental Research. 39: 1193-202. PMID 26010049 DOI: 10.1111/Acer.12737 |
0.571 |
|
| 2015 |
Roche DJ, Ray LA. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment. Pharmacogenomics. 16: 721-36. PMID 25950242 DOI: 10.2217/Pgs.14.143 |
0.59 |
|
| 2015 |
Roche DJ, Bujarski S, Hartwell E, Green R, Ray LA. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers. Pharmacology, Biochemistry, and Behavior. 134: 92-8. PMID 25933795 DOI: 10.1016/J.Pbb.2015.04.013 |
0.503 |
|
| 2015 |
Bujarski S, Roche DJ, Sheets ES, Krull JL, Guzman I, Ray LA. Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study. Experimental and Clinical Psychopharmacology. 23: 81-9. PMID 25844632 DOI: 10.1037/A0038861 |
0.484 |
|
| 2015 |
Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25801501 DOI: 10.1038/Npp.2015.83 |
0.504 |
|
| 2015 |
Roche DJ, King AC. Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase. Psychoneuroendocrinology. 52: 59-71. PMID 25459893 DOI: 10.1016/J.Psyneuen.2014.10.013 |
0.447 |
|
| 2014 |
Ray LA, Roche DJ, Heinzerling K, Shoptaw S. Opportunities for the development of neuroimmune therapies in addiction. International Review of Neurobiology. 118: 381-401. PMID 25175870 DOI: 10.1016/B978-0-12-801284-0.00012-9 |
0.471 |
|
| 2014 |
Bujarski S, Roche DJ, Lunny K, Moallem NR, Courtney KE, Allen V, Hartwell E, Leventhal A, Rohrbaugh T, Ray LA. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug and Alcohol Dependence. 142: 127-32. PMID 24975477 DOI: 10.1016/J.Drugalcdep.2014.06.004 |
0.526 |
|
| 2014 |
Roche DJ, Bujarski S, Moallem NR, Guzman I, Shapiro JR, Ray LA. Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology. 231: 2889-97. PMID 24500677 DOI: 10.1007/S00213-014-3465-X |
0.451 |
|
| 2014 |
Roche DJ, Palmeri MD, King AC. Acute alcohol response phenotype in heavy social drinkers is robust and reproducible. Alcoholism, Clinical and Experimental Research. 38: 844-52. PMID 24117681 DOI: 10.1111/Acer.12280 |
0.596 |
|
| 2013 |
Roche DJ, King AC, Cohoon AJ, Lovallo WR. Hormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy women. Pharmacology, Biochemistry, and Behavior. 109: 84-90. PMID 23672966 DOI: 10.1016/J.Pbb.2013.05.007 |
0.568 |
|
| 2012 |
Childs E, Roche DJ, King AC, de Wit H. Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcoholism, Clinical and Experimental Research. 36: 906-14. PMID 22339626 DOI: 10.1111/J.1530-0277.2011.01675.X |
0.608 |
|
| 2011 |
King AC, Roche DJ, Rueger SY. Subjective responses to alcohol: a paradigm shift may be brewing. Alcoholism, Clinical and Experimental Research. 35: 1726-8. PMID 21919923 DOI: 10.1111/J.1530-0277.2011.01629.X |
0.543 |
|
| 2010 |
Roche DJ, King AC. Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence. Psychopharmacology. 212: 33-44. PMID 20635179 DOI: 10.1007/S00213-010-1906-8 |
0.569 |
|
| 2010 |
Roche DJ, Childs E, Epstein AM, King AC. Acute HPA axis response to naltrexone differs in female vs. male smokers. Psychoneuroendocrinology. 35: 596-606. PMID 19837518 DOI: 10.1016/J.Psyneuen.2009.09.016 |
0.491 |
|
| Show low-probability matches. |